This study extends value-based insurance design concepts in testing the impact on blood pressure control of rewards that provided negative co-payments for blood pressure medication.
J. Otis Smith, EdD
Advertisement
Articles by J. Otis Smith, EdD
This study tests the impact on blood pressure control of a reward that lowered co-payments for blood pressure medication to $0.
Advertisement
Latest Updated Articles
- A Randomized Controlled Trial of Co-Payment Elimination: The CHORD Trial
September 30th 2015
- A Randomized Controlled Trial of Negative Co-Payments: The CHORD Trial
September 30th 2015
Advertisement
Advertisement
Trending on AJMC
1
Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention
2
INHALE-1 Findings Support Inhaled Insulin as a Viable Option for Pediatric Patients: Kevin Kaiserman, MD
3
AI Reshaping Diabetes Care From Nutrition to Clinical Decisions
4
First FDA-Approved Inhaled Insulin for Kids Arrives With Mounting Data: Kevin Kaiserman, MD
5